Evidence map›Paper›PMID 30298314›Full record

ArticleAnnals of surgical oncology2018

Correction to: Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations.

Barbara Schwartzberg, John Lewin, Osama Abdelatif, Jacqueline Bernard, Hanadi Bu-Ali, Simon Cawthorn, Margaret Chen-Seetoo, Sheldon Feldman, Sasirekha Govindarajulu, Lyn Jones and 10 more

Registry-linked trialAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of surgical oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00807924 (American Breast Laser Ablation Therapy Evaluation), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00807924 completednot on this map

American Breast Laser Ablation Therapy Evaluation (ABLATE): Monitoring the Long Term Safety and Efficacy of Novilase™ Breast Interstitial Laser Therapy in Real World Application

TypeobservationalSponsorNovian Health Inc.Ran2008 to 2018Enrolled108ConditionsBenign Breast Conditions, Breast Fibroadenomas
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Barbara SchwartzbergSarah Cannon Research Institute at Rose Medical Center, Denver, CO, USA. scmibs@gmail.com.
John LewinWomen's Imaging Center, Denver, CO, USA.
Osama AbdelatifTucson Pathology Associates, Tucson, AZ, USA.
Jacqueline BernardWalter Reed National Military Medical Center, Bethesda, MD, USA.
Hanadi Bu-AliVirginia Piper Cancer Institute, St. Paul, MN, USA.
Simon CawthornSouthmead Hospital, Bristol, UK.
Margaret Chen-SeetooHerbert Irving Pavilion, Columbia University, New York, NY, USA.
Sheldon FeldmanMontefiore Einstein Center for Cancer Care, Bronx, NY, USA.
Sasirekha GovindarajuluSouthmead Hospital, Bristol, UK.
Lyn JonesSouthmead Hospital, Bristol, UK.
Arne JuetteNorfolk and Norwich University Hospital, Norwich, UK.
Sanjay KaviaBroomfield Hospital, Chelmsford, UK.
Robert MaganiniSt. Alexius Breast Care Center, Bartlett, IL, USA.
Simon PainNorfolk and Norwich University Hospital, Norwich, UK.
Mike ShereSouthmead Hospital, Bristol, UK.
Craig ShriverWalter Reed National Military Medical Center, Bethesda, MD, USA.
Simon SmithBroomfield Hospital, Chelmsford, UK.
Alexandra ValenciaSouthmead Hospital, Bristol, UK.
Eric WhitacreBreast Center of Southern Arizona, Tucson, AZ, USA.
Roger WhitneyBroomfield Hospital, Chelmsford, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The article "Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations", written by Barbara Schwartzberg et al., was originally published electronically on the publisher's internet portal (currently SpringerLink) on July 9, 2018, without open access.

Identifiers

PMID30298314
PMCPMC6828100

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.